Comments on events in the pharmaceutical and biological industry: the “14th five year plan” for the development of medical equipment industry was released, focusing on 7 key areas

event:

Recently, the Ministry of industry and information technology, the National Health Commission, the national development and Reform Commission, the Ministry of science and technology, the Ministry of finance, the SASAC of the State Council, the State Administration of market supervision, the State Medical Insurance Bureau, the State Administration of traditional Chinese medicine, the state food and Drug Administration and other 10 departments jointly issued the medical equipment industry development plan during the 14th five year plan (hereinafter referred to as the plan).

comment:

During the 13th Five Year Plan period, China’s medical equipment industry developed rapidly. During the 13th Five Year Plan period, China’s policy system has been continuously improved, with strong support for scientific research institutions, medical equipment industry, medical system and other parties, forming a product system of more than 1100 categories in 22 categories, covering all links of health and basically meeting the needs of Chinese medical institutions for diagnosis and treatment, elderly care, chronic disease prevention and emergency rescue. According to the data released on the website of the Ministry of industry and information, from 2015 to 2020, China’s medical equipment industry increased from 480 billion yuan to 840 billion yuan, with a CAGR of 11.8%.

The release of the “14th five year plan” for the development of medical equipment industry shows that the state attaches importance to the sustainable development of the field of medical equipment. The 14th Five Year Plan period is a key period for comprehensively promoting the construction of a healthy China, deeply implementing the strategy of manufacturing a powerful country and promoting the high-quality development of the medical equipment industry. The 14th five year plan for the development of the medical equipment industry is the first industrial development plan in the field of medical equipment at the national level. The plan proposes that by 2025, China’s medical equipment industry will significantly improve the level of advanced foundation and industrial chain modernization, basically achieve effective supply of mainstream medical equipment, significantly improve the performance and quality of high-end medical equipment products, and initially form a comprehensive support capacity for public health and medical health needs; By 2035, the R & D, manufacturing and application of China’s medical equipment will be upgraded to the world’s advanced level and enter the forefront of medical equipment innovation countries, so as to provide strong support for ensuring people’s all-round and life-cycle health services.

Pay attention to the seven key areas in the plan, and relevant subdivided industries may benefit. The plan will focus on seven key areas: diagnosis and testing equipment, treatment equipment, monitoring and life support equipment, traditional Chinese medicine diagnosis and treatment equipment, maternal and child health equipment, health care and rehabilitation equipment and active implant intervention equipment, basically covering the needs of the whole population for all-round life-cycle medical and health service equipment from prevention, diagnosis, treatment to health, care and maintenance. Focus on Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) (300760), the leading enterprise of medical equipment platform. It is recommended to focus on Shinva Medical Instrument Co.Ltd(600587) (600587) and Beijing Wandong Medical Technology Co.Ltd(600055) (600055) with rich product lines of medical equipment, Jiangsu Yuyue Medical Equipment And Supply Co.Ltd(002223) (002223) focusing on respiratory, POCT and sensing business, Edan Instruments Inc(300206) (300206) producing products such as monitoring, ECG and maternal and child products, and Xiangyumedicalco.Ltd(688626) (688626) and Nanjing Vishee Medical Technology Co.Ltd(688580) (688580) 。

Risk warning: epidemic prevention and control is not as expected; Risk of intensified market competition; Risks such as changes in industrial policies.

 

- Advertisment -